menu search

Weight loss drug wegovy sales fuel novo nordisk stock performance

Novo Nordisk (NVO) stock rose after the pharmaceutical company reported strong third-quarter sales grow...

November 2, 2023, 2:58 pm

Expect eli lilly's momentum to continue, says bank of america's geoff meacham

Geoff Meacham, Bank of America senior pharmaceutical analyst, joins 'The Exchange' to discuss Eli Lilly...

November 2, 2023, 2:40 pm

Aurinia pharmaceuticals inc. (auph) q3 2023 earnings call transcript

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH ) Q3 2023 Earnings Conference Call November 2, 2023 8:30 AM ET Company Participants Jamie Harrell - Investor...

November 2, 2023, 12:06 pm

Assertio holdings, inc. to release third quarter 2023 financial results on november 8, 2023

LAKE FOREST, Ill., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a specialty ...

November 2, 2023, 12:06 pm

Kura oncology and mirati therapeutics enter into clinical collaboration and supply agreement to evaluate ko-2806 and adagrasib in krasᴳ¹²ᶜ-mutated nsclc

– Ongoing Phase 1 dose-escalation trial of KO-2806 (FIT-001) expected to begin dosing patients in combination with adagrasib by mid-2024 – SAN DIE...

November 2, 2023, 11:30 am

Clearside biomedical announces presentations at the american academy of ophthalmology 2023 annual meeting

– Clinical Data Utilizing Clearside’s Suprachoroidal Delivery Technology to be Featured in Multiple Oral and Poster Presentations – ALPHARETTA, ...

November 2, 2023, 11:05 am

Gsk falls victim of ‘hard to please' pharma market

GSK PLC (LSE:GSK, NYSE:GSK)'s seemingly positive earnings release on Wednesday has been labelled as just that by Stifel analysts, who were left mullin...

November 2, 2023, 11:02 am

This high-yield dividend stock is a proven wealth creator

In 2023, the broader market has ignored the deep value proposition of most large-cap pharmaceutical sto...

November 2, 2023, 10:00 am

In8bio to present new positive data from phase 1 trial of inb-100 at 2023 american society of hematology (ash) annual meeting

NEW YORK, Nov. 02, 2023 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical ...

November 2, 2023, 9:17 am

Corvus pharmaceuticals to present new interim soquelitinib data from its phase 1/1b t cell lymphoma trial at the 65th american society of hematology (ash) annual meeting & exposition

BURLINGAME, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage bio...

November 2, 2023, 9:15 am

Vincerx pharma to present three posters at ash 2023 in december

VIP943 poster supports selectivity and safety of lead CD123 ADC, VIP943, currently in Phase 1 VIP924 poster shows this novel CXCR5-ADC compares favora...

November 2, 2023, 9:10 am

Centessa pharmaceuticals to present additional 52-weeks of continuous treatment data from third year of ongoing phase 2a study of serpinpc for the treatment of hemophilia at american society of hemato

BOSTON and LONDON, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA) today announced that new data from an additional 52-w...

November 2, 2023, 9:09 am

Centessa pharmaceuticals to present additional 52-weeks of continuous treatment data from third year of ongoing phase 2a study of serpinpc for the treatment of hemophilia at american society of hemato

BOSTON and LONDON, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA) today announced that new data from an additional 52-w...

November 2, 2023, 9:09 am

Agios pharmaceuticals to present broad set of clinical and translational data in rare blood disorders at 65th ash annual meeting and exposition

– Both Mitapivat Dose Arms Achieved Statistically Significant Hemoglobin Response in Phase 2 Portion of RISE UP Pivotal Study in Sickle Cell Disease...

November 2, 2023, 9:05 am

Aurinia pharmaceuticals (auph) reports q3 loss, tops revenue estimates

Aurinia Pharmaceuticals (AUPH) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares...

November 2, 2023, 8:16 am

Novabay pharmaceuticals to hold third quarter 2023 conference call on november 9, 2023

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that it will report financial results for the thre...

November 2, 2023, 6:50 am

Regeneron pharma's adjusted earnings beat estimates

Regeneron Pharmaceuticals Inc.'s stock REGN, +1.46% rose fractionally on Thursday after the drug maker said its profit dropped by 23%, while its adjus...

November 2, 2023, 6:49 am

Regeneron beats quarterly profit estimates on eczema treatment strength

Regeneron Pharmaceuticals on Thursday beat Wall Street estimates for third-quarter profit, driven by strong demand for its eczema treatment Dupixent....

November 2, 2023, 6:42 am

Kalvista pharmaceuticals to present data at the 2023 annual scientific meeting of the american college of allergy, asthma & immunology

CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)---- $KALV--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage ...

November 2, 2023, 6:30 am

Hikma pharmaceuticals upgrades guidance for all segments except injectables

Hikma Pharmaceuticals PLC (LSE:HIK, OTC:HKMPF) has upgraded its full-year guidance for two out of three of its business segments following “good mom...

November 2, 2023, 6:26 am


Search within

Pages Search Results: